logo
Despite Trump directive, emergency abortion care is still a legal right

Despite Trump directive, emergency abortion care is still a legal right

Yahoo10-06-2025
In the days since the Trump administration rescinded federal guidance tied to the Emergency Medical Treatment and Labor Act, EMTALA, a wave of alarming headlines has swept across social media:
'Trump just made it legal for hospitals to let pregnant people die.'
'Emergency rooms can now refuse life-saving abortion care.'
As a clinician, I know that isn't true. As a reproductive health strategist, I know those headlines are dangerous. And we all know what happens next: confusion, delay, and harm. Let's be clear — EMTALA is still in effect.
The Emergency Medical Treatment and Labor Act requires hospitals to provide stabilizing emergency care to all patients, regardless of their ability to pay. That includes emergency abortion when it's the necessary treatment to prevent serious harm or death, even in states with abortion bans.
What was rescinded is the Biden-era guidance — a post-Roe clarification that reinforced these obligations and gave clinicians added protections in legally ambiguous states. Without it, hospitals and providers are left to navigate complexity and risk on their own. And in emergency medicine, hesitation can be deadly.
When a provider has to stop and ask, 'Will I get sued or arrested for doing what I know is right?' that delay can cost a life.
Complications can escalate in minutes. And legal fear, not clinical doubt, can make even experienced clinicians pause.
We don't need to wait for another preventable tragedy. We need to act now. We must correct the fear-based narrative and demand clarity and courage from our hospitals.
More opinion: Elon Musk-Trump spat on X is a distraction from the failures of DOGE
Well meaning advocates and organizations have flooded timelines with warnings suggesting emergency abortion care is no longer available. The fear is valid. But the messaging is misleading, and that matters.
When headlines tell the public that hospitals are 'allowed to let women die,' we create a different kind of emergency — one rooted in mistrust. Patients internalize those messages. They begin to doubt the health care system. They wonder if anyone will help them. Some bleed at home instead of going to the ER.
I've already heard from patients who are scared to seek emergency care because they believe hospitals will turn them away. That fear isn't irrational — it's the natural outcome of a system that has failed too many women, including Amber Nicole Thurman, who died in Georgia after being denied abortion care during a miscarriage. Her story is one of several that underscore just how high the stakes are.
And it affects health care providers too. When social media, national news and even advocacy organizations circulate panic without context, our instinct is to pause and wonder if the legal ground has shifted again.
In medicine, uncertainty delays care. And in emergency medicine, that delay can be fatal.
Here's what's still true:
EMTALA is still in effect.
Hospitals are still required to provide abortion when it's the necessary emergency treatment.
Patients still have the right to receive stabilizing care.
But rights only matter if people trust they can use them, and clinicians can only act if they trust their institutions will back them up.
We must sound the alarm, but we cannot afford to fuel panic. Because fear doesn't just spread — it paralyzes. And that paralysis costs lives.
While courts and lawmakers dominate the headlines, we must remember that hospital systems are power players, too. They're institutions with boards, reputations, legal teams and responsibility.
Every hospital in the U.S. — especially those in abortion-restricted states — should be urgently reviewing their EMTALA protocols, issuing clear guidance to staff and publicly affirming that abortion will be provided when medically necessary.
Silence from leadership isn't neutrality. It's complicity — and it's deadly.
Providers need to know they'll be protected for doing their jobs. Patients need to know their care won't be delayed by legal ambiguity. The moment of crisis is not the time to call a lawyer or fumble through a policy binder. Hospitals must act before the next emergency, not after.
We have a constitutional mandate. Let's lead like it.
In 2022, Michigan voters passed Proposal 3 by a wide margin, enshrining the right to reproductive freedom, including abortion, into our state constitution. That makes this moment even easier for our hospitals — a no-brainer, if you will.
We have legal clarity. We have the public mandate. Now we have a responsibility to lead by example for the rest of the country.
We've seen what happens when hospitals fail to lead. A ProPublica investigation in Texas found that after the state's abortion ban took effect, the sepsis rate among pregnant patients in Houston surged by 63%. In Dallas — where hospitals empowered doctors to act — it rose by just 29%. The difference? Hospital policy.
Some institutions supported their clinicians. Others left them to weigh legal risk against patient safety. People suffered. Some died.
Michigan's hospitals don't face the same legal barriers. We've enshrined reproductive rights into our constitution. The only question now is whether our institutions will rise to meet this moment — not just for Michiganders, but as a model for the nation.
We have the opportunity to set a precedent of leadership. Of valor. Of honoring the Hippocratic Oath and protecting half of our population. This is a chance to show that when legal clarity and public support align, health systems don't hesitate — they lead.
To Corewell Health, Henry Ford Health, Trinity Health Michigan, McLaren Health Care, Michigan Medicine and the Detroit Medical Center: this is your moment.
Issue clear EMTALA guidance. Protect your providers. Affirm your commitment to emergency abortion care loudly and publicly.
And to Gov. Gretchen Whitmer: Michigan has already set a national example by enshrining reproductive freedom into our state constitution. Now, we need your leadership again. Issue state-based guidance that reinforces EMTALA protections and directs hospitals to act swiftly and decisively when patients need life-saving abortion care.
Then go one step further.
Call on your fellow governors, especially in states where abortion is banned. Governors like Andy Beshear in Kentucky. If they said they were 'sending it back to the states,' then let's show them what the states can do. Let's show the country what leadership looks like when it centers care, not politics.
Because silence is not safety, and neutrality is not leadership.
More opinion: Democrats better hope Michigan Gov. Whitmer changes her mind about presidential run
If you're reading this from another state, you're not powerless.
Call your local hospital and ask if they have clear EMTALA guidance for emergency pregnancy care. Push your lawmakers to require transparency and protect providers. Share accurate information — panic spreads fast, but facts save lives. Support front-line providers who are navigating unclear laws with courage.
Even without constitutional protections, your voice can demand clarity, accountability and care. Hospitals everywhere need to hear it.
Nikki Vinckier is an OBGYN physician assistant, reproductive rights advocate and founder of Take Back Trust, a national patient education platform helping people navigate and protect their reproductive health care.
This article originally appeared on Detroit Free Press: Emergency abortion still a legal right despite Trump move | Opinion
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

94 Palestinians killed in Gaza, including 45 people waiting for aid, authorities say
94 Palestinians killed in Gaza, including 45 people waiting for aid, authorities say

Los Angeles Times

time33 minutes ago

  • Los Angeles Times

94 Palestinians killed in Gaza, including 45 people waiting for aid, authorities say

TEL AVIV, Israel — Airstrikes and shootings killed 94 Palestinians in Gaza overnight, including 45 who were attempting to get much-needed humanitarian aid, hospitals and the Health Ministry said Thursday. Israel's military did not immediately comment on the strikes. Five people were killed while outside sites associated with the Gaza Humanitarian Foundation, the newly-created, secretive American organization backed by Israel to feed the Gaza Strip's population, while 40 others were killed waiting for aid in other locations across the Gaza Strip. On Thursday, human rights organization Amnesty International issued a report claiming Israel and the foundation have 'militarized' the aid distribution system as a starvation tactic against Palestinians. 'Israel has continued to use starvation of civilians as a weapon of war against Palestinians in the occupied Gaza Strip and to deliberately impose conditions of life calculated to bring about their physical destruction as part of its ongoing genocide,' the report said. The organization had previously accused Israel of committing genocide in a report last December. Israel has adamantly rejected the allegations, and is challenging such claims at the International Court of Justice. Dozens of people were killed in airstrikes that pounded the Strip Wednesday night and Thursday morning, including 15 people killed in strikes that hit tents in the sprawling Muwasi zone, where many displaced Palestinians are sheltering. A separate strike on a school in Gaza City sheltering displaced people also killed 15 people. Gaza's Health Ministry said the number of Palestinians killed in Gaza has passed 57,000 since the war began on Oct. 7, 2023. The toll includes 223 people who had been missing but have now been declared dead. The ministry doesn't differentiate between civilians and combatants in its death count but says that more than half of the dead are women and children. The deaths come as Israel and Hamas inch closer to a possible ceasefire that would end the 21-month war. Trump said Tuesday that Israel had agreed on terms for a 60-day ceasefire in Gaza and urged Hamas to accept the deal before conditions worsen. But Hamas' response, which emphasized its demand that the war end, raised questions about whether the latest offer could materialize into an actual pause in fighting. The Israeli military blames Hamas for the civilian casualties because it operates from populated areas. The military said it targeted Hamas militants and rocket launchers in northern Gaza that launched rockets toward Israel on Wednesday. Amnesty condemned both Israel and the Gaza Humanitarian Foundation, which the U.S. and Israel have tapped to take over aid distribution in Gaza from a network led by the United Nations. The Amnesty report said Israel has 'turned aid-seeking into a booby trap for desperate starved Palestinians' through the foundation's militarized hubs. The conditions have created 'a deadly mix of hunger and disease pushing the population past breaking point,' it said. Israel's foreign ministry denounced the Amnesty report, saying the organization has 'joined forces with Hamas and fully adopted all of its propaganda lies.' Gaza's Health Ministry says more than 500 Palestinians have been killed at or near the foundation distribution centers over the past month, including five overnight between Wednesday and Thursday in Khan Younis. The centers are guarded by private security contractors and located near Israeli military positions. Palestinian officials and witnesses have accused Israeli forces of opening fire at crowds of people moving near the sites. The war began when Hamas-led militants attacked southern Israel, killing 1,200 people and taking roughly 250 hostages. The war has left the coastal Palestinian territory in ruins, with much of the urban landscape flattened in the fighting. More than 90% of Gaza's 2.3 million population has been displaced, often multiple times. And the war has sparked a humanitarian crisis in Gaza, leaving hundreds of thousands of people hungry. Lidman and Chehayeb write for the Associated Press. Chehayeb reported from Beirut.

RBC Sees Limited Exposure to Medicaid Risks for Tenet (THC), Reiterated $189 Target
RBC Sees Limited Exposure to Medicaid Risks for Tenet (THC), Reiterated $189 Target

Yahoo

timean hour ago

  • Yahoo

RBC Sees Limited Exposure to Medicaid Risks for Tenet (THC), Reiterated $189 Target

Tenet Healthcare Corporation (NYSE:THC) is one of the 20 undervalued momentum stocks that are taking off. On June 11, RBC Capital analyst Ben Hendrix reiterated a Buy rating on Tenet Healthcare (THC), maintaining a price target of $189. The reaffirmation follows recent volatility in hospital stocks triggered by a White House memo regarding Medicaid supplemental payment programs. While the memo raised concerns, particularly around potential reductions in state-directed payments, Hendrix views the market reaction as overdone. He notes that the language in the memo aligns with that in the current budget bill that allow for the continuation, or 'grandfathering,' of existing programs. Therefore, in his view, the memo does not introduce any new or material headwinds for hospital earnings. A successful healthcare provider smiling confidently in a modern hospital facility. Hendrix sees the pullback in hospital names as a buying opportunity, especially for acute care providers like HCA Healthcare, Community Health, Ardent Health, and, notably, Tenet. He believes Tenet is well-positioned due to its relatively lower exposure to the Medicaid-directed payment programs that have come under scrutiny. This could help the company remain insulated, and do relatively better compared to its peers. Therefore, Tenet remains the analyst's top pick in the hospital sector. He believes that the recent weakness in the stock offers a more attractive entry point for long-term investors. Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company that operates a nationwide care delivery network, including ambulatory surgery centers, surgical hospitals, and a national portfolio of acute care and specialty hospitals. While we acknowledge the potential of THC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and 10 Best Tech Stocks to Buy According to Billionaires. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release
H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release

Yahoo

timean hour ago

  • Yahoo

H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release

Wave Life Sciences Ltd. (NASDAQ:WVE) ranks among the best CRISPR stocks to buy. On June 23, H.C. Wainwright maintained its $22 price target and Buy rating on Wave Life Sciences Ltd. (NASDAQ:WVE). The rating, in line with the strong analyst consensus on the company, follows new preclinical evidence that was presented at the 85th ADA meeting in Chicago. The firm cited data from WAVE's WVE-007 program that showed that in diet-induced obese mice, lowering INHBE mRNA with a single subcutaneous injection of INHBE-03 led to considerable weight loss. More specifically, the preclinical findings showed that the only way treated mice lost weight was by losing fat mass in their epididymal white adipose tissue; in contrast, the quadricep muscle mass, which is a crucial therapeutic differentiator, was constant. Wave Life Sciences Ltd. (NASDAQ:WVE) is a clinical-stage biotechnology company that employs PRISM, a platform for drug research and discovery, to create and market RNA (ribonucleic acid) therapies. While we acknowledge the potential of WVE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store